Logo Image
News
OncClubAll Oncology NewsClinical Trials in Focus
Media
InsightsMedNews WeekOncChatsOncLive News Network®OncLive TVPeer ExchangePodcastsRapid ReadoutsShorts
Conferences
Conference CoverageConference Listing
Events
Giants of Cancer CareCME/CEScientific InterchangesState of the Science Summit / IPCNational Fellows ForumWebinars
More
Partners
Publications
All PublicationsSupplements
Resources
Consensus ViewpointsOncLive AppInteractive ToolsSponsored
Biomarker Consortium

Subscribe

  • News
  • Media
  • Conferences
  • Events
  • Partners
  • Publications
  • Resources
  • Biomarker Consortium
  • Subscribe
  • AI for Oncology
  • Biosimilars
  • Brain Cancer
  • Breast Cancer
    • HER2+ Breast Cancer
  • CAR T-Cell Therapy
  • Disparities in Cancer Care
  • Gastrointestinal Cancer
    • Pancreatic Cancer
    • Hepatocellular Carcinoma
    • Gastric Cancer
    • Colorectal Cancer
  • Genitourinary Cancers
    • Urothelial Cancer
    • Prostate Cancer
  • Global Oncology
  • Graft-vs-Host Disease
  • Gynecologic Oncology
    • Ovarian Cancer
  • Head & Neck Cancers
  • Hematologic Oncology
    • Chronic Lymphocytic Leukemia
    • Non-Hodgkin Lymphoma
    • Mantle Cell Lymphoma
    • Multiple Myeloma
    • Myeloproliferative Neoplasms
  • Immuno-Oncology
  • Lung Cancer
  • Melanoma & Skin Cancer
  • Oncology Business Management
  • Pediatric Oncology
  • Precision Medicine in Oncology®
  • Sarcomas
  • Supportive Care
Spotlight -
The OncLive Insider app is live!|
CME Opportunities
Advertisement

Anne Favret, MD

Advertisement

Articles by Anne Favret, MD

Dr. Favret on Extending Survival and Improving Outcomes in Breast Cancer

ByAnne Favret, MD
June 3rd 2020

Anne Favret, MD, discusses the importance of clinical trials in the breast cancer space.

Dr. Favret on the Evolution of Treatment in HER2+ Breast Cancer

ByAnne Favret, MD
May 4th 2020

Anne Favret, MD, discusses the evolution of treatment in HER2-positive breast cancer.

Advertisement

Latest Updated Articles

  • Dr. Favret on the Evolution of Treatment in HER2+ Breast Cancer
    Dr. Favret on the Evolution of Treatment in HER2+ Breast Cancer

    May 4th 2020

  • Dr. Favret on Extending Survival and Improving Outcomes in Breast Cancer
    Dr. Favret on Extending Survival and Improving Outcomes in Breast Cancer

    June 3rd 2020



Advertisement
Advertisement

Trending on OncLive

1

ctDNA Status Has Strong Prognostic Value, Outperforming pCR Status, in Early TNBC

2

CELMoDs and Bispecifics Break Through Across Lymphomas and Leukemias at EHA 2026

3

The OncFive: Top Oncology Articles for the Week of 5/31

4

From Toilet Cleaner to Thoracic Oncologist and Patient: How Ross Camidge Built a Life Worth Loving

5

FDA Grants Priority Review to Giredestrant for ER-Positive Early Breast Cancer

  • Advertise
  • About OncLive
  • Editorial Board
  • MJH Life Sciences brands
  • Contact Us
  • Privacy
  • Terms & Conditions
  • Do Not Sell My Information
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

Brand Logo
Download on Apple
Download on Google Play

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us